Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Neumora Therapeutics Inc (NASDAQ: NMRA) was $2.19 for the day, down -1.35% from the previous closing price of $2.22. In other words, the price has decreased by -$1.35 from its previous closing price. On the day, 0.67 million shares were traded. NMRA stock price reached its highest trading level at $2.2495 during the session, while it also had its lowest trading level at $2.16.
Ratios:
Our analysis of NMRA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.85 and its Current Ratio is at 6.85. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.
On October 27, 2025, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $14.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 11 ’25 when Aurora Daljit Singh sold 114,703 shares for $2.68 per share. The transaction valued at 307,026 led to the insider holds 0 shares of the business.
Aurora Family Trust bought 114,703 shares of NMRA for $307,027 on Nov 11 ’25. On Oct 27 ’25, another insider, Burow Kristina, who serves as the Director of the company, bought 1,915,700 shares for $2.61 each. As a result, the insider paid 4,999,977 and bolstered with 6,046,907 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 372165216 and an Enterprise Value of 219498832.
Stock Price History:
The Beta on a monthly basis for NMRA is 3.15, which has changed by -0.786333 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, NMRA has reached a high of $11.57, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is -3.82%, while the 200-Day Moving Average is calculated to be 48.33%.
Shares Statistics:
NMRA traded an average of 1.57M shares per day over the past three months and 1213710 shares per day over the past ten days. A total of 161.95M shares are outstanding, with a floating share count of 54.47M. Insiders hold about 67.40% of the company’s shares, while institutions hold 19.04% stake in the company. Shares short for NMRA as of 1763078400 were 6095137 with a Short Ratio of 3.87, compared to 1760486400 on 6788203. Therefore, it implies a Short% of Shares Outstanding of 6095137 and a Short% of Float of 9.54.
Earnings Estimates
Neumora Therapeutics Inc (NMRA) is presently subject to a detailed evaluation by 7.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.26 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$1.39 and -$1.47 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$1.03, with 7.0 analysts recommending between -$0.63 and -$1.45.
